PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
14530681-3	2003	METHODS: We quantitatively determined tumor epidermal growth factor receptor levels in 38 patients with colorectal cancer compared with adjacent normal mucosa by iodine-125-labeled epidermal growth factor binding studies and Scatchard analysis.	Iodine-125	162-172	epidermal growth factor receptor	Homo sapiens	44-76	
15185528-2	2004	For a period of 2 years EGFR expression was studied in 23 patients having malignant ovarian tumors by 125I-labelled human epidermal growth factor and recombinant human epidermal growth factor.	Iodine-125	102-106	epidermal growth factor receptor	Homo sapiens	24-28	
8132599-5	1994	The activity of the expressed chimeric proteins was determined by their ability to compete with 125I-labeled mouse EGF for binding to NIH-3T3 cells transfected with the hEGF receptor.	Iodine-125	96-100	epidermal growth factor receptor	Homo sapiens	169-182	
9085135-1	1997	Chloroquine has been shown to increase the cellular retention and nuclear incorporation of 125I-labeled monoclonal antibody (MAb) 425, a murine anti-epidermal growth factor receptor monoclonal antibody, in human high-grade glioma cells in vitro.	Iodine-125	91-95	epidermal growth factor receptor	Homo sapiens	149-181	
8722428-0	1996	The use of epidermal growth factor receptor-425 monoclonal antibodies radiolabeled with iodine-125 in the adjuvant treatment of patients with high grade gliomas of the brain.	Iodine-125	88-98	epidermal growth factor receptor	Homo sapiens	11-43	
11985614-4	2002	Nevertheless, the chimeras with domain III of ErbB-1 and domain I of ErbB-4 were prevented from binding to 125I-labeled EGF competitively by the ErbB-4 ligand, neuregulin (NRG).	Iodine-125	107-111	epidermal growth factor receptor	Homo sapiens	46-52	
9988932-1	1998	The data confirmed the fact that repeated administrations of iodine-125 labeled anti-epidermal growth factor receptor 425 is safe and may have benefited the management of primary high grade gliomas of the brain as well as recurrent astrocytomas.	Iodine-125	61-71	epidermal growth factor receptor	Homo sapiens	85-117	
7590764-0	1995	Epidermal growth factor receptor 425 monoclonal antibodies radiolabeled with iodine-125 in the adjuvant treatment of high-grade astrocytomas.	Iodine-125	77-87	epidermal growth factor receptor	Homo sapiens	0-32	
1514524-0	1992	Radiotoxicity of 125I-labeled monoclonal antibody 425 against cancer cells containing epidermal growth factor receptor.	Iodine-125	17-21	epidermal growth factor receptor	Homo sapiens	86-118	
1727372-0	1992	Immunotherapy of human glioma xenografts with unlabeled, 131I-, or 125I-labeled monoclonal antibody 425 to epidermal growth factor receptor.	Iodine-125	67-71	epidermal growth factor receptor	Homo sapiens	107-139	
1727372-7	1992	Our studies provide the rationale for immunotherapy of glioma patients with either unlabeled or 125I-labeled anti-epidermal growth factor receptor mAb 425.	Iodine-125	96-100	epidermal growth factor receptor	Homo sapiens	114-146	
1309204-0	1992	Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: a phase II trial.	Iodine-125	36-46	epidermal growth factor receptor	Homo sapiens	87-119	
2783320-1	1989	The effect of the human rIL-1 alpha and rTNF-alpha on the binding of 125I-labeled epidermal growth factor ([125I]EGF) to its receptor (EGF-R) has been studied in human gingival fibroblasts (HuGi).	Iodine-125	69-73	epidermal growth factor receptor	Homo sapiens	135-140	
3260004-1	1988	Epidermal growth factor (EGF) receptor was affinity labeled with 125I-labeled EGF, using bifunctional covalent cross-linking agents.	Iodine-125	65-69	epidermal growth factor receptor	Homo sapiens	0-38	
3193478-1	1988	Iodine-125-labeled monoclonal antibody 108.4 (108.4 mAb), raised against the extracellular domain of the epidermal growth factor (EGF) receptor, was shown to visualize sc xenografts of human oral epidermoid carcinoma (KB) cells in nude mice.	Iodine-125	0-10	epidermal growth factor receptor	Homo sapiens	105-143	
2446740-1	1988	The expression of epidermal growth factor (EGF) receptor was examined immunohistochemically in a total of 122 gastric and 61 colonic carcinomas, out of which 16 gastric and 8 colonic carcinomas were also examined by 125I-labeled EGF binding analysis and Western blotting.	Iodine-125	216-220	epidermal growth factor receptor	Homo sapiens	18-56	
6251452-3	1980	Furthermore, 125I-labeled EGF incubated with cells in the presence of methylamine becomes increasingly insensitive to trypsin with time, suggesting that the EGF receptor internalization is not prevented by alkylamines, but that there is an intracellular accumulation of ligand--receptor complex due to the loss of normal modes of ligand-induced receptor processing.	Iodine-125	13-17	epidermal growth factor receptor	Homo sapiens	157-169	
23107475-8	2012	The cytotoxic effectiveness of [125I]SGMIB-MNT compared with 125I-labeled bovine serum albumin control was enhanced by a factor of 60 for D247 MG cells and more than 1,000-fold for A431 cells, which express higher levels of EGFR.	Iodine-125	32-36	epidermal growth factor receptor	Homo sapiens	224-228